147 related articles for article (PubMed ID: 18695904)
1. GFP image analysis in the mouse orthotopic bladder cancer model.
De Velasco MA; Tanaka M; Anai S; Tomioka A; Nishio K; Uemura H
Oncol Rep; 2008 Sep; 20(3):543-7. PubMed ID: 18695904
[TBL] [Abstract][Full Text] [Related]
2. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
3. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI
Clin Cancer Res; 2008 Mar; 14(5):1510-8. PubMed ID: 18316576
[TBL] [Abstract][Full Text] [Related]
4. Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression.
Zhou JH; Rosser CJ; Tanaka M; Yang M; Baranov E; Hoffman RM; Benedict WF
Cancer Gene Ther; 2002 Aug; 9(8):681-6. PubMed ID: 12136429
[TBL] [Abstract][Full Text] [Related]
5. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
[TBL] [Abstract][Full Text] [Related]
6. [Whole-body fluorescent imaging of the growth and metastasis of GFP-expressing bladder tumors].
Wu YD; Tan WL; Xie Y; Yu ZC; Zhao GZ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):436-40. PubMed ID: 16624746
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of response to chemotherapy in orthotopic xenografts of human bladder cancer.
Mazurchuk R; Glaves D; Raghavan D
Clin Cancer Res; 1997 Sep; 3(9):1635-41. PubMed ID: 9815854
[TBL] [Abstract][Full Text] [Related]
8. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
[TBL] [Abstract][Full Text] [Related]
9. Novel bifunctional anthracycline and nitrosourea chemotherapy for human bladder cancer: analysis in a preclinical survival model.
Glaves D; Murray MK; Raghavan D
Clin Cancer Res; 1996 Aug; 2(8):1315-9. PubMed ID: 9816302
[TBL] [Abstract][Full Text] [Related]
10. The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.
Yang M; Burton DW; Geller J; Hillegonds DJ; Hastings RH; Deftos LJ; Hoffman RM
Clin Cancer Res; 2006 Apr; 12(8):2602-6. PubMed ID: 16638872
[TBL] [Abstract][Full Text] [Related]
11. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
Wu Q; Mahendran R; Esuvaranathan K
Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
[TBL] [Abstract][Full Text] [Related]
12. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
Hadaschik BA; Jackson J; Fazli L; Zoubeidi A; Burt HM; Gleave ME; So AI
BJU Int; 2008 Aug; 102(5):610-6. PubMed ID: 18384625
[TBL] [Abstract][Full Text] [Related]
13. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.
Kawano H; Komaba S; Yamasaki T; Maeda M; Kimura Y; Maeda A; Kaneda Y
Cancer Chemother Pharmacol; 2008 May; 61(6):973-8. PubMed ID: 17653716
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
[TBL] [Abstract][Full Text] [Related]
15. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
Li C; Yan RP; Yuan GH; Feng YG; Wang JS; Gao X; Huang YS; Zhou JB; Xie SS
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782
[TBL] [Abstract][Full Text] [Related]
16. [A simple and efficient method for establishing a mouse model of orthotopic MB49 bladder cancer].
Liang ZK; Zhang L; Hu ZM; Chen Z; Huang X; Shi XH; Tan WL; Gao JM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):627-30. PubMed ID: 19403380
[TBL] [Abstract][Full Text] [Related]
17. Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors.
Zang Z; Mahendran R; Wu Q; Yong T; Esuvaranathan K
Int J Mol Med; 2004 Oct; 14(4):713-7. PubMed ID: 15375606
[TBL] [Abstract][Full Text] [Related]
18. [A new animal model for intravesical chemotherapy of bladder cancer].
Yamashita T; Ito J
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2087-92. PubMed ID: 2456038
[TBL] [Abstract][Full Text] [Related]
19. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
Hadaschik BA; Black PC; Sea JC; Metwalli AR; Fazli L; Dinney CP; Gleave ME; So AI
BJU Int; 2007 Dec; 100(6):1377-84. PubMed ID: 17850390
[TBL] [Abstract][Full Text] [Related]
20. Vaccinia virus mediated p53 gene therapy for bladder cancer in an orthotopic murine model.
Fodor I; Timiryasova T; Denes B; Yoshida J; Ruckle H; Lilly M
J Urol; 2005 Feb; 173(2):604-9. PubMed ID: 15643273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
